PSL reported modest results in 2QFY25, impacted by inflationary pressures. Significant inflation in palm oil, coupled with increased duties in September, is anticipated to negatively impact 3Q FY25.
Krishna Institute of Medical Sciences (KIMS) reported a robust 19.4% y-o-y increase in Total Income during 2QFY25, reaching Rs 782.3 crore. Calculated blended occupancy rate (basis total bed capacity) was 49.7% in 2Q FY25, compared to 47.8% in 1Q FY25.
Emami’s reported fair sales growth in 2Q FY25 as higher food inflation negatively affected discretionary consumption. Management expects demand to improve in the second half of the financial year, driven by a predicted good winter season.
Subros reported a modest revenue growth of 1.8% y-o-y in 2Q FY25, whilst 1H FY25 sales increased 8.7% y-o-y led by higher volume and Start of Production (SOP) of new business award. Quarterly EBITDA increased 8.9% y-o-y while EBITDA margin expanded 60 bps to 9.2%.
EFC reported strong growth in 2Q FY25 as revenues increased by 72.9% y-o-y to Rs 171.1 crore. EBITDA increased 103.4% y-o-y to Rs 84.0 crore as EBITDA margin expanded by 736 bps y-o-y to 49.1%.
Sharda Cropchem Limited (SCL) reported solid growth in 2Q FY25 as revenues increased by 33.8% y-o-y to Rs 776.9 crore. A volume growth of 21% y-o-y was driven by strong performance at the agrochemical segment with Europe being the key contributor.
Home First Finance Company (HFFC) reported strong 2Q FY25 results with continued momentum in disbursals (Rs 1,177 crore, +22.7% y-o-y, +1.2% q-o-q). AUM exhibited robust growth to reach Rs 11,229 crore (+34.2% y-o-y, +7.2% q-o-q).
Krishna Institute of Medical Sciences (KIMS) reported healthy y-o-y growth in 1Q FY25 with consolidated operating revenues increasing by 13.8% to Rs 693 crore. Calculated blended occupancy rate (basis total bed capacity) was 49.8% in 1Q FY25, compared to 51.4% in 4Q FY24.